Renaissance Group’s NeoGenomics NEO Stock Holding History

Renaissance Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-41,646	Closed	-$329K	–	284
2017 Q1	$329K	Buy	41,646 +470	+1%	+$3.83K	0.01%	232
2016 Q4	$353K	Buy	+41,176	New	+$353K	0.01%	198
2015 Q4	–	Sell	-42,100	Closed	-$241K	–	290
2015 Q3	$241K	Hold	42,100	–	–	0.01%	250
2015 Q2	$228K	Buy	+42,100	New	+$217K	0.01%	250

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Renaissance Group's NEO Position: Q2 2017 in Review

Renaissance Group sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 41,646 shares — an estimated $329K sold.

Renaissance Group first reported a position in NEO in Q2 2015 and held it in 4 quarters. The position peaked at $353K in Q4 2016. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Renaissance Group reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
Renaissance Group sold 41,646 NeoGenomics shares in Q2 2017, an estimated $329K.
Renaissance Group first reported a position in NeoGenomics in Q2 2015 and held it in 4 quarters.
Renaissance Group's NeoGenomics position peaked at $353K in Q4 2016.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Renaissance Group's 13F filing for Q2 2017, filed 8 Aug 2017.